Document is current
Any future updates will be listed below
-
Authors
Yang, Su-jin
Wang, Dan-dan
Zhong, Shan-liang
Chen, Wen-quan
Wang, Feng-liang
Zhang, Jian
Xu, Wen-xiu
Xu, Di
Zhang, Qian
Li, Jian
Zhang, He-da
Hou, Jun-chen
Mao, Ling
Tang, Jin-hai
-
Funding
Funding for this research was provided by:
Basic Research Program of Jiangsu Province
Huai`an Natural Science Research Plan
- License Information
-
More Information
Article History
Received: 25 November 2020
Revised: 21 March 2021
Accepted: 26 March 2021
First Online: 28 April 2021
Ethics approval and consent to participate
: The authors state that they have obtained appropriate institutional review board approval or have followed the principles outlined in the Declaration of Helsinki for all human or animal experimental investigations. All serum samples from breast cancer patients were in accordance with the ethical guidelines of Nanjing Medical University, and all patients were given written informed consent before the study. The animal studies were approved by the Animal Care and Use Committee of Nanjing Medical University (acceptance no.: IACUC 1903021) and complied with the guidelines of the National Institutes of Health.
: All authors have given consent to publish the manuscript in <i>Cell Death & Disease</i>.
: The authors declare no competing interests.
